中药及其单体成分治疗儿童注意缺陷多动障碍的研究进展  

Research advance of traditional Chinese medicines and monomer components in the treatment of ADHD

作　　者：王娣 杨智峰[1] 卫向峰 WANG Di;YANG Zhi-feng;WEI Xiangfeng(Shanxi Academy of Traditional Chinese Medicine,Xi'an 710003,China;不详)

机构地区：[1]陕西省中医药研究院,西安710003 [2]西安中医脑病医院,西安710032

出　　处：《中国处方药》2021年第4期31-33,共3页Journal of China Prescription Drug

基　　金：陕西省中药创新药物研究中心项目(2017YWZX-02)。

摘　　要：儿童注意缺陷多动障碍(ADHD)是一种发病率较高的儿童神经发育障碍性疾病,其病因尚不完全清楚。目前临床常用治疗药物存在停药反应、复发率高等缺点,而中药对ADHD治疗具有显著的疗效,且不良反应较少。本文通过对治疗ADHD的中药及其单体成分进行汇总归纳,以期为治疗ADHD中药新药的研发提供新的思路和理论依据。Children attention deficit hyperactivity disorder is a neurodevelopmental disorder with high incidence in children,whose cause is not fully understood.At present,the commonly used clinical treatment drugs have the disadvantages of drug withdrawal reaction and high recurrence rate,while traditional Chinese medicine has a significant effect on ADHD with fewer adverse reactions.By summarizing the traditional Chinese medicine and its monomer components for the treatment of ADHD,this paper hopes to provide new ideas and theoretical basis for the research and development of new traditional Chinese medicine for the treatment of ADHD.

关 键 词：注意缺陷多动障碍 中药 单体成分 

分 类 号：R749.94[医药卫生—神经病学与精神病学]